Literature DB >> 22001395

Opposite effects of ANP receptors in attenuation of LPS-induced endothelial permeability and lung injury.

Junjie Xing1, Bakhtiyor Yakubov, Valeriy Poroyko, Anna A Birukova.   

Abstract

Atrial natriuretic peptide (ANP) has been recently identified as a modulator of acute lung injury (ALI) induced by pro-inflammatory agonists. While previous studies tested effects of exogenous ANP administration, the role of endogenous ANP in the course of ALI remains unexplored. This study examined regulation of ANP and its receptors NPR-A, NPR-B and NPR-C by LPS and involvement of ANP receptors in the modulation of LPS-induced lung injury. Primary cultures of human pulmonary endothelial cells (EC) were used in the in vitro tests. Expression of ANP and its receptors was determined by quantitative RT-PCR analysis. Agonist-induced cytoskeletal remodeling was evaluated by immunofluorescence staining, and EC barrier function was characterized by measurements of transendothelial electrical resistance. In the murine model of ALI, LPS-induced lung injury was assessed by measurements of protein concentration and cell count in bronchoalveolar lavage fluid (BAL). LPS stimulation significantly increased mRNA expression levels of ANP and NPR-A in pulmonary EC. Pharmacological inhibition of NPR-A augmented LPS-induced EC permeability and blocked barrier protective effects of exogenous ANP on LPS-induced intercellular gap formation. In contrast, pharmacological inhibition of ANP clearance receptor NPR-C significantly attenuated LPS-induced barrier disruptive effects. Administration of NPR-A inhibitor in vivo exacerbated LPS-induced lung injury, whereas inhibition of NPR-C suppressed LPS-induced increases in BAL cell count and protein content. These results demonstrate for the first time opposite effects of NPR-A and NPR-C in the modulation of ALI and suggest a compensatory protective mechanism of endogenous ANP in the maintenance of lung vascular permeability in ALI. Copyright Â
© 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001395      PMCID: PMC3278549          DOI: 10.1016/j.mvr.2011.09.012

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  40 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR.

Authors:  T D Schmittgen; B A Zakrajsek
Journal:  J Biochem Biophys Methods       Date:  2000-11-20

3.  Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1.

Authors:  Anna A Birukova; Junjie Xing; Panfeng Fu; Bakhtiyor Yakubov; Oleksii Dubrovskyi; Jennifer A Fortune; Alexander M Klibanov; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-20       Impact factor: 5.464

4.  Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction.

Authors:  Junjie Xing; Nurgul Moldobaeva; Anna A Birukova
Journal:  J Appl Physiol (1985)       Date:  2010-11-04

5.  Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase.

Authors:  K N Pandey; H T Nguyen; M Li; J W Boyle
Journal:  Biochem Biophys Res Commun       Date:  2000-05-10       Impact factor: 3.575

6.  Plasma levels of atrial natriuretic peptide in severe burn injury.

Authors:  G N Onuoha; E K Alpar; J Gowar
Journal:  Burns       Date:  2000-08       Impact factor: 2.744

7.  Polar head groups are important for barrier-protective effects of oxidized phospholipids on pulmonary endothelium.

Authors:  Anna A Birukova; Panfeng Fu; Santipongse Chatchavalvanich; Dylan Burdette; Olga Oskolkova; Valery N Bochkov; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-12-08       Impact factor: 5.464

8.  Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF.

Authors:  Anna A Birukova; Ivan Cokic; Nurgul Moldobaeva; Konstantin G Birukov
Journal:  Am J Respir Cell Mol Biol       Date:  2008-07-29       Impact factor: 6.914

9.  ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha.

Authors:  Junjie Xing; Anna A Birukova
Journal:  Microvasc Res       Date:  2009-11-26       Impact factor: 3.514

10.  Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection.

Authors:  Anna A Birukova; Tatiana Zagranichnaya; Elena Alekseeva; Gary M Bokoch; Konstantin G Birukov
Journal:  J Cell Physiol       Date:  2008-06       Impact factor: 6.384

View more
  3 in total

1.  Lipopolysaccharide Induces Alveolar Macrophage Necrosis via CD14 and the P2X7 Receptor Leading to Interleukin-1α Release.

Authors:  Jargalsaikhan Dagvadorj; Kenichi Shimada; Shuang Chen; Heather D Jones; Gantsetseg Tumurkhuu; Wenxuan Zhang; Kolja A Wawrowsky; Timothy R Crother; Moshe Arditi
Journal:  Immunity       Date:  2015-04-07       Impact factor: 31.745

2.  Role of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide.

Authors:  Yufeng Tian; Isa Mambetsariev; Nicolene Sarich; Fanyong Meng; Anna A Birukova
Journal:  Biochim Biophys Acta       Date:  2014-10-27

3.  Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunction.

Authors:  Fanyong Meng; Angelo Meliton; Nurgul Moldobaeva; Gokhan Mutlu; Yoshihiro Kawasaki; Tetsu Akiyama; Anna A Birukova
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-24       Impact factor: 5.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.